A study of over 2,500 people found common medications, including antibiotics and antidepressants, can cause lasting changes to the gut microbiome for years after use.
A new oral GLP-1 drug, aleniglipron, showed significant weight loss of up to 12.1% in a 36-week trial, offering a potential alternative to injectable medications.
A lab study found that many common sweeteners can alter gut bacteria growth, with significant effects when combined with medications like the antidepressant duloxetine.
A traditional Chinese medicinal root, Polygonum multiflorum, is showing potential as a multi-faceted treatment for androgenetic alopecia, according to a new scientific review.
New research indicates genetic variants may cause GLP-1 drug resistance in about 10% of the population, impacting Type 2 diabetes treatment effectiveness.
A clinical trial found that the common constipation drug lubiprostone may slow the progression of chronic kidney disease by altering gut bacteria and improving mitochondrial function.
A new study reveals that the amino acid arginine can significantly reduce toxic amyloid protein buildup and inflammation in animal models of Alzheimer's disease.